Related Experiment Video

Updated: Jun 16, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation

Yanyuan Wu1, Monica Alvarez, Dennis J Slamon

  • 1Division of Cancer Research and Training, Department of Internal Medicine, Charles R, Drew University of Medicine and Science, Los Angeles, CA 90059, USA.

BMC Cancer
|February 6, 2010
PubMed
Abstract

Insights

Promoter methylation silences tumor suppressor genes like CASP8 and maspin in breast cancer. Demethylating agents can restore gene expression, offering potential new therapies for breast cancer patients.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Research

Background:

  • Epigenetic alterations, specifically promoter DNA methylation, are implicated in tumor suppressor gene silencing.
  • This silencing increases the risk of tumor formation and cancer progression.

Purpose of the Study:

  • To investigate the promoter methylation status of Caspase 8 (CASP8) and maspin in breast cancer cell lines.
  • To explore the potential of demethylating agents in restoring the expression of these genes.

Main Methods:

  • Methylation-specific PCR (MSP) and bisulfite sequencing were employed to assess promoter methylation.
  • Chromatin immunoprecipitation (CHIP) assays were used to examine histone H3 methylation.
  • Gene expression was analyzed following treatment with demethylating agents like 5-aza-2'-deoxycytidine (5-aza-dc).

Main Results:

  • CASP8 and maspin promoter methylation was detected in breast cancer cell lines but absent in non-tumorigenic lines.
  • 5-aza-dc treatment restored CASP8 and maspin gene expression in breast cancer cells.
  • Combination therapy with 5-aza-dc and Trichostatin A (TSA) further modulated histone modifications and increased CASP8 expression.

Conclusions:

  • Promoter methylation of CASP8 and maspin contributes to their reduced expression in breast cancer.
  • Demethylating agents show promise as a therapeutic strategy for breast cancer by reactivating silenced tumor suppressor genes.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...